The use of intravenous immunoglobulins in the treatment of factor VIII inhibitors.
Sultan
Y
Y
Centre d'Accueil et de Traitement des Hémophiles, Hôpital Cochin, Paris, France.
Kazatchkine
M D
MD
Algiman
M
M
Dietrich
G
G
Nydegger
U
U
D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000097:blood; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D005260:Female; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D000888:Antibodies, Anti-Idiotypic; D016756:Immunoglobulins, Intravenous; D005169:Factor VIII